Atlas Trials

An Umbrella Trial Based on Molecular Pathway for Patients With Metastatic TNBC.

Clinical trial NCT04395989 · UNKNOWN

Trial details

NCT number
NCT04395989
Sponsor
Fudan University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
TNBC - Triple-Negative Breast Cancer
Start date
2020-07-28
Primary completion
2023-05-31
Enrollment
139

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.